Comparing the Effectiveness of Triamcinolone Acetonide and Vitamin D3 Injections in Treating Spot baldness
Phase 4
- Conditions
- Health Condition 1: L63- Alopecia areata
- Registration Number
- CTRI/2024/07/070467
- Lead Sponsor
- Medha Mishra
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Non-scarring, patchy hair loss over the scalp.
Patients who have not received any treatment for Alopecia areata in past 4 weeks.
Exclusion Criteria
1.Individuals under 18 years of age.
2.Women who are pregnant and lactating.
3.Patients with local site skin infection.
4.Patients on Immunosuppresants.
5.Patients with underlying malignancies.
6.Patients taking Vitamin D supplements in last 6 months.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Improvement of SALT Scoring and Digital Photography.Timepoint: 3rd week 6th week 9th week and 12th week <br/ ><br>
- Secondary Outcome Measures
Name Time Method Adverse drug reactionTimepoint: 3, 6, 9 and 12th week